insights_auto
Why is AKTX up 19,02%?
Dive Deeperchevron_right
AKTX:NASDAQ
Akari Therapeutics PLC
8,66 US$
arrow_upward
+19,02%(+1,38) 1D
15 ოქტ, 15:32:41 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AKTX...
Open
7,87 US$
High
8,89 US$
Low
7,00 US$
Mkt. cap
19,80 მლნ.
Avg. vol.
64,81 ათ.
Volume
52,07 ათ.
52-wk high
36,44 US$
52-wk low
3,02 US$
EPS
-330,40 US$
Beta
1,43
Shares outstanding
1,14 მლნ.
No. of employees
5
Open
7,87 US$
High
8,89 US$
Low
7,00 US$
Mkt. cap
19,80 მლნ.
Avg. vol.
64,81 ათ.
Volume
52,07 ათ.
52-wk high
36,44 US$
52-wk low
3,02 US$
EPS
-330,40 US$
Beta
1,43
Shares outstanding
1,14 მლნ.
No. of employees
5
News stories
From web sources and news partners
www.marketscreener.com
·
3 საათის წინ
Akari Therapeutics, plc Advances Aktx-101 Toward Planned Phase 1 Clinical Development
Yahoo Finance
·
6 საათის წინ
Akari Therapeutics CEO Highlights Differentiated ADC Payload Strategy and Path Toward Clinical Development in New CEO Corner
Stock Titan
·
6 საათის წინ
When antibody-linked cancer drugs stop helping, options may narrow. Akari is developing a different active drug.
Investing.com Canada
·
19 საათის წინ
Form 4 Akari Therapeutics PLC ADR: Vatnak Vat-Ho (Chief Business Officer) For: 12 October
About Akari Therapeutics PLC
CEO-
Employees5
Founded2004
Headquartersტამპა, ფლორიდა, ამერიკის შეერთებული შტატები
Sector-
Websiteakaritx.com